Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Clin Breast Cancer. 2013 Oct 26;14(3):205–211. doi: 10.1016/j.clbc.2013.10.018

Figure 3.

Figure 3

Rashes observed with protocol therapy A. Grade 1 maculopapular rash (subject 7, cycle 3 day 1). B. Grade 2 maculopapular rash (subject 42, cycle 3 day 7). C. Grade 3 desquamating rash (subject 41, cycle 3 day 1). D. Resolving acral erythrodysesthesia (subject 41).